Entrectinib in locally advanced/metastatic ROS1 and NTRK fusion-positive non-small cell lung cancer (NSCLC): Updated integrated analysis of STARTRK-2, STARTRK-1 and ALKA-372-001 Meeting Abstract


Authors: de Braud, F.; Siena, S.; Barlesi, F.; Drilon, A.; Simmons, B.; Huang, X.; Osborne, S.; Doebele, R. C.
Abstract Title: Entrectinib in locally advanced/metastatic ROS1 and NTRK fusion-positive non-small cell lung cancer (NSCLC): Updated integrated analysis of STARTRK-2, STARTRK-1 and ALKA-372-001
Meeting Title: 2019 ESMO Asia Congress
Journal Title: Annals of Oncology
Volume: 30
Issue: Suppl. 9
Meeting Dates: 2019 Nov 22-24
Meeting Location: Singapore
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2019-11-01
Start Page: mdz420.003
Language: English
ACCESSION: WOS:000503487700064
PROVIDER: wos
DOI: 10.1093/annonc/mdz420.003
Notes: Meeting Abstract: 64P -- Appears on pages ix24-ix25 of the abstract book -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Edward Drilon
    632 Drilon